lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

V-9302, a competitive small-molecule antagonist of transmembrane glutamine flux, leads to reduced cancer cell growth and proliferation, increased cell death, and increased oxidative stress through the pharmacological blockade of ASCT2, and these activities together promote antitumor responses in vitro and in vivo [180]

The detailed interrelationships and interdependencies between substances that damage the epithelial barrier, the intestinal microbiota, the immune system, the development of inflammation, changes in cell function and ultimately the development of diseases, often located distantly from the intestine, remain unclear

8B, Ctrl)

Biol Trace Elem Res 201(7):33003310

Association between Guillain-Barr syndrome and COVID-19 infection and vaccination: a population-based nested case-control study